Theozin® (Theophylline/ Guaifenesin)

Theozin® (Theophylline/ Guaifenesin)

Attributes

Category Generic Name Brand
Bronchodilator and Anti-asthma drugs Theophylline/ Guaifenesin Theozin®
Dosage Form Dosage Packing
Syrup (50/30) mg/ 5 ml 120 ml

Theozin® (Theophylline/ Guaifenesin)


General Description
Side Effects Hives, difficulty breathing, swelling of your face, lips, tongue, or throat, seizure (convulsions), fast or uneven heart rate, severe nausea or vomiting
Direction of use Adult: In adults not currently taking theophylline or xanthine-containing products a suggested loading dose is 5 mg/kg, to produce an average peak serum concentration of 10 micrograms/mL. Doses should again be reduced in the elderly and those with cor pulmonale, heart failure, or liver disease; smokers may require a higher maintenance dose. In the long-term management of chronic bronchospasm, theophylline may be given orally in doses ranging from 300 to 1000 mg daily in divided doses (generally given every 6 to 8 hours). Pediatric: Premature infants should be given initial doses of 1 mg/kg every 12 hours if less than 24 days postnatal age, or 1.5 mg/kg every 12 hours if more than 24 days; in full-term infants up to 1 year of age initial daily dosage (to be given in 3 or 4 divided doses) could be calculated on the basis of the equation: Daily dose (mg/kg) = (0.2 × age in weeks) + 5.0 Subsequent dosage should be adjusted based on steady-state serum-theophylline concentrations, which might take as long as 5 days to be achieved in premature neonates if a loading dose is not used.
Warnings Allergy to any ingredient in guaifenesin/theophylline (including ethylenediamine), similar medicines (eg, aminophylline), or xanthines (eg, caffeine, chocolate) • Concurrent use of large amounts of other products that contain xanthine (such as chocolate or caffeinated drinks) • Untreated ulcers or a seizure disorder • Concurrent use with dipyridamole intravenously (IV), halothane, or St. John’s wort
Catalog Theozin® (Theophylline/ Guaifenesin) Catalog
Menu